Article

Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis.

Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
The Journal of clinical investigation (Impact Factor: 13.77). 04/2010; 120(5):1515-23. DOI: 10.1172/JCI40802
Source: PubMed

ABSTRACT Chronic stress is associated with hormonal changes that are known to affect multiple systems, including the immune and endocrine systems, but the effects of stress on cancer growth and progression are not fully understood. Here, we demonstrate that human ovarian cancer cells exposed to either norepinephrine or epinephrine exhibit lower levels of anoikis, the process by which cells enter apoptosis when separated from ECM and neighboring cells. In an orthotopic mouse model of human ovarian cancer, restraint stress and the associated increases in norepinephrine and epinephrine protected the tumor cells from anoikis and promoted their growth by activating focal adhesion kinase (FAK). These effects involved phosphorylation of FAKY397, which was itself associated with actin-dependent Src interaction with membrane-associated FAK. Importantly, in human ovarian cancer patients, behavioral states related to greater adrenergic activity were associated with higher levels of pFAKY397, which was in turn linked to substantially accelerated mortality. These data suggest that FAK modulation by stress hormones, especially norepinephrine and epinephrine, can contribute to tumor progression in patients with ovarian cancer and may point to potential new therapeutic targets for cancer management.

Download full-text

Full-text

Available from: Pablo E Vivas-Mejia, Jul 12, 2015
1 Follower
 · 
130 Views
  • Source
    • "Furthermore, besides cancer cells, stromal cells in the tumor microenvironment could also be affected by the nervous system [7] [8]. Studies of ovarian cancer have demonstrated that NE/E may contribute to tumor progression by promoting angiogenesis [9]. By a large-scale cDNA transfection screening, our previous study revealed that many neurotransmitter receptor-related genes are closely associated with cancer cell proliferation and survival [10]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Monoamine oxidase A (MAOA), a catecholamine neurotransmitter degrading enzyme, is closely associated with neurological and psychiatric disorders. However, its role in cancer progression remains unknown. Hepatocellular carcinoma (HCC) tissue arrays (n=254) were used to investigate the correlation between MAOA expression and clinicopathological findings. In vitro invasion and anoikis assays, and in vivo intrahepatic and lung metastasis models were used to determine the role of MAOA in HCC metastasis. Quantitative real-time PCR, western blotting, immunohistochemical staining and HPLC analysis were performed to uncover the mechanism of MAOA in HCC. We found that MAOA expression was significantly downregulated in 254 clinical HCC samples and was closely correlated with cancer vasoinvasion, metastasis and poor prognoses. We then demonstrated that MAOA suppressed norepinephrine/epinephrine (NE/E)-induced HCC invasion and anoikis inhibition, and uncovered that the effects of NE/E on HCC behaviors were primarily mediated through alpha 1A (ADRA1A) and beta 2 adrenergic receptors (ADRB2). In addition to the canonical signaling pathway, which is mediated via adrenergic receptors (ADRs), we found that ADR-mediated EGFR transactivation was also involved in NE-induced HCC invasion and anoikis inhibition. Notably, we found that MAOA could synergize with EGFR inhibitors or ADR antagonists to abrogate NE-induced HCC behaviors. Taken together, the results of our study may provide insights into the application of MAOA as a novel predictor of clinical outcomes and indicate that increasing MAOA expression or enzyme activity may be a new approach that can be used for HCC treatment.
    Journal of Hepatology 03/2014; 60. DOI:10.1016/j.jhep.2014.02.025 · 10.40 Impact Factor
  • Source
    • "Anti-apoptosis Tumour growth Angiogenesis Migration invasion Propranolol [24] [25] [36] [57] [61] [99] [100] "
    [Show abstract] [Hide abstract]
    ABSTRACT: β-Adrenoceptors are broadly distributed in various tissues of the body. Stress hormones regulate a panel of important physiological functions and disease states including cancer. Nicotine and its derivatives could stimulate the release of stress hormones from cancer cells, leading to the promotion of cancer development. β-blockers have been widely used to control hypertension for decades. Recently, these agents could have significant implications in cancer therapy through blockade of adrenoceptors in tumor tissues. In this review, we summarize recent advancements about the influence of stress hormones, nicotine and β-adrenoceptors on cancer cell proliferation, apoptosis, invasion and metastasis, and also tumor vasculature normalization. Relevant signal pathways and potential value of β-blockers in the treatment of cancer are also discussed in this review.
    Seminars in Cancer Biology 09/2013; 23(6). DOI:10.1016/j.semcancer.2013.08.009 · 9.33 Impact Factor
  • Source
    • "Many studies have shown that chronic stress can increase tumor development and/or disease progression (e.g., metastsis of solid tumors or dissemination of hematopoietic tumors). Pharmacologic and molecular dissection of these models has identified a diverse array of gene modules that appear to play a role in mediating such effects, including glucocorticoid-induced activation of the SGK1 gene and associated inhibition of the key tumor suppressor p53 (Feng et al., 2012), and b-adrenergic induction of genes involved in macrophage recruitment and inflammation (Sloan et al., 2010), induction of pro-inflammatory cytokine genes such as IL6 and IL8 by tumor cells (Cole et al., 2010; Nilsson et al., 2007; Shahzad et al., 2010) and immune cells (Cole et al., 2010), VEGF-mediated increases in angiogenesis (Chakroborty et al., 2009; Thaker et al., 2006; Yang et al., 2006), matrix metalloproteinase-related increases in tissue invasion (Landen et al., 2007; Sood et al., 2006; Yang et al., 2006), tumor cell mobilization and motility (Drell et al., 2003; Lang et al., 2004; Palm et al., 2006), FAKmediated resistance to anoikis/apoptosis (Sood et al., 2010), BADmediated resistance to chemotherapy-induced apoptosis (Sastry et al., 2007), and RANKL-mediated modulation of osteoclast function and bone metastasis (Campbell et al., 2012). Other studies have also shown that glucocorticoids can up-regulate a diverse array of genes involved in cell survival and resistance to chemotherapy (Kamradt et al., 2000a; Mikosz et al., 2001; Moran et al., 2000; Pang et al., 2006; Petrella et al., 2006; Wu et al., 2004, 2005), and activate oncogenic viruses such as Epstein–Barr Virus (EBV) (Cacioppo et al., 2002; Glaser et al., 1995; Yang et al., 2010) and Human Papilloma Viruses (Kamradt et al., 2000b; Mittal et al., 1993; Pater et al., 1988), and that b-adrenergic signaling can inhibit p53-med- iated DNA repair (Hara et al., 2011), inhibit expression of Type I interferons (Collado-Hidalgo et al., 2006; Sloan et al., 2010) and interleukin 12 (Goldfarb et al., 2011), upregulate the Her2 signaling pathway implicated in breast cancer (Gu et al., 2009; Shi et al., 2011), stimulate arachadonic acid signaling (Cakir et al., 2002), activate gene expression by tumor-promoting viruses such as HHV-8 (Antoni et al., 2006; Chang et al., 2005), and upregulate the SNAI2 transcription factor regulating epithelial–mesenchymal transition (S. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Genomics-based analyses have provided deep insight into the basic biology of cancer and are now clarifying the molecular pathways by which psychological and social factors can regulate tumor cell gene expression and genome evolution. This review summarizes basic and clinical research on neural and endocrine regulation of the cancer genome and its interactions with the surrounding tumor microenvironment, including the specific types of genes subject to neural and endocrine regulation, the signal transduction pathways that mediate such effects, and therapeutic approaches that might be deployed to mitigate their impact. Beta-adrenergic signaling from the sympathetic nervous system has been found to up-regulated a diverse array of genes that contribute to tumor progression and metastasis, whereas glucocorticoid-regulated genes can inhibit DNA repair and promote cancer cell survival and resistance to chemotherapy. Relationships between socio-environmental risk factors, neural and endocrine signaling to the tumor microenvironment, and transcriptional responses by cancer cells and surrounding stromal cells are providing new mechanistic insights into the social epidemiology of cancer, new therapeutic approaches for protecting the health of cancer patients, and new molecular biomarkers for assessing the impact of behavioral and pharmacologic interventions.
    Brain Behavior and Immunity 11/2012; 30. DOI:10.1016/j.bbi.2012.11.008 · 6.13 Impact Factor
Show more